In gastric cancer cells, TGF-β-driven RUNX3 antagonized WNT-signaling via a RUNX3/TCF4/β-catenin complex (Lee et al., 2010), which in our model would result in suppression of hypertrophy (Diederichs et al., 2019). Here, RUNX3 is linked to gastric cancer.